Study to investigate changes in airway inflammation, symptoms, and rescue therapy utilization with AIRSUPRA compared to albuterol as needed in adults with mild asthma

Trial Identifier: D6930C00018
Sponsor: AstraZeneca
Collaborator:
Fortrea
Start Date: September 2024
Primary Completion Date: February 2026
Study Completion Date: February 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, AZ Phoenix, AZ, US, 85040
US, AZ Tucson, AZ, US, 85715
US, CA Lancaster, CA, US, 93534
US, CA San Diego, CA, US, 92123
US, FL Cape Coral, FL, US, 33990
US, FL Lake Worth, FL, US, 33462
US, GA Columbus, GA, US, 31904
US, ID Boise, ID, US, 83706
US, IN Plainfield, IN, US, 46168
US, MO Saint Louis, MO, US, 63141
US, NJ Riverdale, NJ, US, 07457
US, OK Oklahoma City, OK, US, 73120
US, SC North Charleston, SC, US, 29420
US, TX El Paso, TX, US, 79903
US, TX Houston, TX, US, 77030
US, TX Waco, TX, US, 76712